|
Bridging Genetics and Diagnosis in Type 1 and Type 2 Diabetes: The Role of Polymorphisms
|
| |
|
|
|
چکیده: (7 مشاهده) |
Diabetes mellitus, encompassing type 1 (T1D) and type 2 diabetes (T2D), is a major global health burden with rapidly increasing prevalence. T1D is characterized by autoimmune destruction of pancreatic β-cells, whereas T2D primarily involves insulin resistance and β-cell dysfunction. Despite advances in clinical and molecular research, gaps remain in understanding the genetic architecture and gene–environment interactions driving disease onset and progression. This review summarizes current evidence on genetic polymorphisms associated with T1D and T2D, with a focus on their roles in disease susceptibility, complications, and potential therapeutic implications. In T1D, variants in the HLA region, INS, and PTPN22 have been strongly linked to autoimmunity and β-cell vulnerability. In T2D, genes such as TCF7L2, KCNJ11, SLC30A8, and EPO influence insulin secretion, glucose homeostasis, and risk modulation, with loss-of-function mutations in SLC30A8 showing protective effects. Emerging data highlight how genetic variants interact with zinc metabolism, inflammatory pathways, and environmental factors to shape disease heterogeneity. Additionally, polymorphisms in both T1D- and T2D-associated genes contribute to the risk of long-term complications, including nephropathy, retinopathy, and cardiovascular disease. By integrating evidence from genome-wide association studies, next-generation sequencing, and functional analyses, this review emphasizes the diagnostic and prognostic value of genetic markers. Understanding these genetic insights not only enhances risk prediction and early diagnosis but also supports the development of precision medicine approaches tailored to individual genetic backgrounds.
|
|
| |
|
|
متن کامل [PDF 273 kb]
(3 دریافت)
|
نوع مطالعه: مروری |
موضوع مقاله:
عمومى
دریافت: 1404/10/20 | پذیرش: 1405/1/18 | انتشار: 1404/3/9
|
|
|
|
|
|
|
| ارسال نظر درباره این مقاله |
|
|
|
